Wound Care Joint Ventures: Partnership Growth Models

Wound Care Joint Ventures: How Partnerships Accelerate Practice Growth

Wound care joint ventures are structured partnerships that let practices access resources, patient volume, and clinical capabilities they couldn't build independently. For a mobile wound care practice generating consistent revenue but limited by geography or clinical scope, a well-structured JV can compress three years of organic growth into twelve months.

The challenge is that healthcare joint ventures operate under regulatory constraints that don't apply to other industries. Anti-Kickback Statute, Stark Law, and state-level corporate practice of medicine rules all shape what's permissible. A handshake arrangement that would be perfectly legal between two landscaping companies can result in federal fraud charges between two healthcare entities.

This article covers the JV models that work in wound care, the legal guardrails you need to respect, and how to structure partnerships that survive the operational reality of running a clinical business with a partner.

Hospital-Practice Partnership Models

The most common wound care JV is between an independent practice and a hospital or health system. Hospitals have patient volume, facility infrastructure, and referral networks. Independent practices have clinical specialization, operational flexibility, and the ability to see patients in settings hospitals don't reach.

The Under-Arrangement Model

In this model, the hospital contracts with your wound care practice to provide services within the hospital's outpatient wound care center. The hospital bills under its own provider number and pays your practice a management fee or per-visit rate.

This isn't technically a joint venture -- it's a management services agreement. But it functions like one for practices that want access to hospital patient volume without the capital and regulatory complexity of a true equity JV. The economics are simpler, the compliance risk is lower, and the exit is cleaner if the relationship doesn't work.

The downside is control. The hospital sets the policies, chooses the EHR, determines scheduling parameters, and owns the patient relationships. You're a vendor, not a partner. If the hospital decides to bring wound care in-house, your contract terminates.

The Equity Joint Venture

A true equity JV creates a new legal entity -- typically an LLC -- jointly owned by the hospital and your practice. Both parties contribute capital, share governance, and split profits according to an operating agreement.

This structure works when both parties bring something the other genuinely needs. The hospital contributes patient volume, facility space, and administrative infrastructure. Your practice contributes clinical expertise, mobile capabilities, and the ability to extend wound care into SNFs, home health, and other post-acute settings the hospital's employed providers don't cover.

Equity JVs require careful compliance structuring. The ownership percentages must reflect legitimate capital contributions and fair market value, not referral volume. An ownership split that correlates with the number of patients referred from one party to another will draw scrutiny from OIG.

Surgeon and Specialist Partnerships

Wound care practices frequently receive referrals from vascular surgeons, podiatrists, and orthopedic surgeons. In some markets, formalizing these referral relationships into structured partnerships creates mutual benefit.

The co-management model works well with surgical practices. The surgeon handles operative interventions -- vascular procedures, amputations, reconstructive surgery. Your wound care practice handles pre-operative wound optimization and post-operative wound management. Rather than operating as separate practices with informal referral patterns, a co-management agreement defines the clinical protocols, documentation standards, and financial terms.

This model doesn't require equity sharing. A written co-management agreement that defines each party's clinical responsibilities, compensation methodology, and performance standards is sufficient. The compensation must reflect fair market value for services actually rendered -- not a disguised referral fee.

The multi-specialty group model takes this further. Your wound care practice and one or more surgical practices form a single entity that provides comprehensive lower extremity or wound management services. Patients enter the group and receive coordinated care without the friction of inter-practice referrals.

For how these partnership structures align with the SNF referral channel, see Wound Care SNF Partnership Model.

Legal and Compliance Considerations

Healthcare JVs fail more often because of compliance problems than business problems. The regulatory framework is designed to prevent arrangements where money flows in exchange for patient referrals, even when the arrangement has legitimate clinical value.

Anti-Kickback Statute (AKS): Any JV where one party refers patients to the other party -- and money changes hands in any direction -- must fit within an AKS safe harbor. The investment interest safe harbor (42 CFR 1001.952(a)) has specific requirements: returns must be proportional to capital invested, the arrangement can't require referrals as a condition of investment, and the entity can't loan or guarantee funds for investors.

Stark Law: If the JV involves designated health services (which wound care procedures are) and physician referrals, the arrangement must qualify for a Stark exception. The in-office ancillary services exception, the fair market value exception, and the bona fide employment exception are the most commonly used.

Corporate Practice of Medicine (CPOM): In states with CPOM restrictions, a hospital (a corporate entity) cannot directly employ physicians or control clinical decision-making. This affects JV structure -- the physician practice typically maintains clinical autonomy through a professional corporation or management arrangement, even within a JV.

Get a healthcare attorney involved before you sign a term sheet. Not a general business attorney. Not your malpractice insurer's attorney. A healthcare regulatory attorney who structures JVs regularly and understands the interplay between federal and state rules in your specific market.

Profit Sharing and Governance

The operating agreement is where JVs succeed or fail. Two issues matter more than everything else: how profits are distributed and how decisions are made.

Profit distribution should follow capital contribution ratios, not referral volume. If you own 40% of the JV, you receive 40% of the distributions. Period. Variable distributions that reward referral activity -- even indirectly -- create compliance exposure.

Governance should define decision authority for three categories: day-to-day clinical operations (usually delegated to the managing partner), financial decisions above a threshold (typically requires unanimous consent), and strategic decisions like expansion, new service lines, or additional partners (also requiring unanimous consent or supermajority).

Build in a dispute resolution mechanism. JV partners disagree. It's inevitable. Having a defined process -- mediation before arbitration, for example -- prevents disputes from paralyzing the business. Also define buyout terms upfront: what triggers a buyout, how the entity is valued, and what the payment timeline looks like. Negotiating exit terms when both parties are amicable is dramatically easier than negotiating them during a dispute.

For how JV revenue flows integrate with overall practice economics, see Wound Care Practice Revenue Model.

Key Takeaways

Hospital-practice JVs come in two primary forms: management arrangements (lower risk, lower control) and equity joint ventures (higher commitment, shared governance), each with distinct compliance profiles
Surgeon partnerships work best as co-management agreements where clinical responsibilities and fair market value compensation are clearly defined, rather than as disguised referral arrangements
Every healthcare JV must be structured to comply with Anti-Kickback Statute, Stark Law, and applicable state corporate practice of medicine rules before any patient referrals flow
Profit distribution must follow capital contribution ratios, not referral volume, and governance terms should define decision authority for clinical, financial, and strategic categories
Engage a healthcare regulatory attorney -- not a general business attorney -- before signing any term sheet for a wound care partnership